Raymond James & Associates Cel Sci Corp Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

A detailed history of Raymond James & Associates transactions in Cel Sci Corp stock. As of the latest transaction made, Raymond James & Associates holds 18,878 shares of CVM stock, worth $11,515. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,878

Previous 18,878 -0.0%

Holding current value

$11,515

Previous $21,000 4.76%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 16, 2024	BUY	$1.07 - $3.07 $527 - $1,513	493 Added 2.68%	18,878 $51,000
Q4 2022 Feb 08, 2023	SELL	$1.99 - $3.52 $2,485 - $4,396	-1,249 Reduced 6.36%	18,385 $43,000
Q3 2022 Oct 25, 2022	BUY	$3.09 - $5.23 $769 - $1,302	249 Added 1.28%	19,634 $61,000
Q4 2021 Feb 08, 2022	SELL	$7.1 - $12.82 $63 - $115	-9 Reduced 0.05%	19,385 $138,000
Q3 2021 Nov 02, 2021	SELL	$7.64 - $12.49 $45 - $74	-6 Reduced 0.03%	19,394 $213,000
Q2 2021 Aug 11, 2021	BUY	$8.68 - $27.49 $17,707 - $56,079	2,040 Added 11.75%	19,400 $168,000
Q1 2021 May 14, 2021	SELL	$12.0 - $27.64 $12,504 - $28,800	-1,042 Reduced 5.66%	17,360 $264,000
Q4 2020 Feb 12, 2021	SELL	$11.05 - $16.62 $35,890 - $53,981	-3,248 Reduced 15.0%	18,402 $215,000
Q2 2020 Jul 28, 2020	BUY	$9.75 - $17.6 $83,538 - $150,796	8,568 Added 65.49%	21,650 $323,000
Q1 2020 Apr 21, 2020	SELL	$7.54 - $17.05 $1,447 - $3,273	-192 Reduced 1.45%	13,082 $151,000
Q4 2019 Feb 12, 2020	BUY	$6.71 - $9.55 $838 - $1,193	125 Added 0.95%	13,274 $121,000
Q3 2019 Nov 07, 2019	SELL	$6.0 - $9.6 $4,944 - $7,910	-824 Reduced 5.9%	13,149 $118,000
Q2 2019 Aug 06, 2019	SELL	$3.77 - $8.67 $161,265 - $370,867	-42,776 Reduced 75.38%	13,973 $117,000
Q1 2019 May 06, 2019	SELL	$2.58 - $3.54 $41,925 - $57,525	-16,250 Reduced 22.26%	56,749 $201,000
Q4 2018 Feb 11, 2019	SELL	$2.65 - $4.26 $4,229 - $6,798	-1,596 Reduced 2.14%	72,999 $210,000
Q3 2018 Nov 14, 2018	BUY	$0.83 - $4.16 $61,913 - $310,315	74,595 New	74,595 $302,000

Others Institutions Holding CVM

# of Institutions

Shares Held

Call Options Held

27.1K

Put Options Held

150K

View Full List

About CEL SCI CORP

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $26.5M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

More about CVM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Cel Sci Corp Transaction History